The Plasmodium berghei sexual stage antigen PSOP12 induces anti-malarial transmission blocking immunity both in vivo and in vitro. by Sala, K, Nishiura, H, Upton, L, Zakutansky, SE, Delves, M, Iyori, M, Mizutani, M, Sinden, R, Yoshida, S, Blagborough, A

Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations. by Upton, L, Brock, P, Churcher, T, Ghani, A, Gething, P, Delves, M, Sala, K, Leroy, D, Sinden, R, Blagborough, A

Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax by Blagborough, A, Musiychuk, K, Bi, H, Jones, R, Chichester, J, Streatfield, S, Sala, K, Zakutansky, S, Upton, L, Sinden, R, Brian, I, Biswas, S, Sattabonkot, J, Yusibov, V

Adenovirus-prime and baculovirus-boost heterologous immunization achieves sterile protection against malaria sporozoite challenge in a murine model. by Yoshida, K, Iyori, M, Blagborough, A, Salman, A, Dulal, P, Sala, K, Yamamoto, D, Khan, S, Janse, C, Biswas, S, Yoshii, T, Yusuf, Y, Tokoro, M, Hill, A, Yoshida, S